Azur Pharma Limited

Azur Pharma is a private pharmaceutical company focused on US specialty markets. The company is headquartered in Dublin, Ireland. Azur Pharma markets a portfolio of prescription products through its US national sales infrastructure consisting of 90 sales representatives. Azur's portfolio comprises FazaClo®, Gastrocrom®, and twelve urology and women's health products which are marketed through its Pharmelle business. FazaClo® is an antipsychotic drug indicated for the management of severely ill schizophrenic patients who fail to respond to standard treatments. Gastrocrom® is indicated for the management of patients with mastocytosis.